NOVA1 Antikörper (Internal Region)
-
- Target Alle NOVA1 Antikörper anzeigen
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NOVA1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Verwendungszweck
- NOVA1
- Sequenz
- REMPQNVAKT EPVS
- Spezifität
- This antibody is expected to recognise all three reported isoforms (NP_002506.2 , NP_006480.2 , NP_006482.1)
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Immunogen
- Peptide with sequence C-REMPQNVAKTEPVS, from the internal region of the protein sequence according to NP_002506.2 , NP_006480.2 , NP_006482.1.
- Isotyp
- IgG
- Top Product
- Discover our top product NOVA1 Primärantikörper
-
-
- Applikationshinweise
-
Immunohistochemistry: Paraffin embedded Human Brain (Cortex) and Heart. Recommended concentration: 5 μg/mL.
Western Blot: Approx 50-55 kDa band observed in Human Breast Cancer lysates (calculated MW of 51.7 kDa according to NP_002506.2). In transfected HEK293 transiently expressing NOVA1 a band of approx. 52 kDa is observed. This band is not observed in the non-t
Peptide ELISA: antibody detection limit dilution 1:64000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
- Andere Bezeichnung
- NOVA1 (NOVA1 Produkte)
- Synonyme
- Nova-1 antikoerper, NOVA1 antikoerper, si:ch211-222c22.9 antikoerper, 9430099M15Rik antikoerper, G630039L02 antikoerper, NOVA alternative splicing regulator 1 antikoerper, neuro-oncological ventral antigen 1 L homeolog antikoerper, neuro-oncological ventral antigen 1 antikoerper, RNA-binding protein Nova-1 antikoerper, lipid A export ATP-binding/permease protein antikoerper, NOVA1 antikoerper, Nova1 antikoerper, nova1.L antikoerper, nova1 antikoerper, LOC790874 antikoerper, novA1 antikoerper
- Hintergrund
- NOVA1, neuro-oncological ventral antigen 1, Nova-1, paraneoplastic Ri antigen, ventral neuron-specific protein 1
- Gen-ID
- 4857
- NCBI Accession
- NP_002506, NP_006480, NP_006482
-